Burkhard L. Herrmann

553 total citations
11 papers, 412 citations indexed

About

Burkhard L. Herrmann is a scholar working on Infectious Diseases, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Burkhard L. Herrmann has authored 11 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Infectious Diseases, 3 papers in Molecular Biology and 2 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Burkhard L. Herrmann's work include SARS-CoV-2 and COVID-19 Research (3 papers), COVID-19 Clinical Research Studies (3 papers) and Pituitary Gland Disorders and Treatments (2 papers). Burkhard L. Herrmann is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (3 papers), COVID-19 Clinical Research Studies (3 papers) and Pituitary Gland Disorders and Treatments (2 papers). Burkhard L. Herrmann collaborates with scholars based in Germany and United Kingdom. Burkhard L. Herrmann's co-authors include Bernhard Saller, Klaus Mann, Onno E. Janßen, Andreas Bockisch, Peter Gocke, M. Broecker, H. Sperling, Klaus Mann, Michael Buchfelder and Günter K. Stalla and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, American Heart Journal and Clinical Endocrinology.

In The Last Decade

Burkhard L. Herrmann

11 papers receiving 402 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Burkhard L. Herrmann Germany 8 211 119 103 91 78 11 412
Elisabete Rodrigues Brazil 10 121 0.6× 61 0.5× 113 1.1× 96 1.1× 43 0.6× 38 365
M.T. Muñoz-Calvo Spain 9 93 0.4× 58 0.5× 60 0.6× 69 0.8× 26 0.3× 21 268
Veerle Bogaert Belgium 11 230 1.1× 79 0.7× 84 0.8× 199 2.2× 35 0.4× 12 455
François Rey Switzerland 13 275 1.3× 51 0.4× 124 1.2× 93 1.0× 74 0.9× 22 507
Sumika Matsui Japan 11 109 0.5× 46 0.4× 153 1.5× 60 0.7× 14 0.2× 31 374
Anastasia Armeni Greece 12 124 0.6× 55 0.5× 154 1.5× 37 0.4× 14 0.2× 33 401
P H Rayner United Kingdom 15 283 1.3× 127 1.1× 43 0.4× 135 1.5× 109 1.4× 40 553
Ruiyi Tang China 13 144 0.7× 77 0.6× 131 1.3× 92 1.0× 27 0.3× 46 460
C Preeyasombat Thailand 12 267 1.3× 65 0.5× 38 0.4× 110 1.2× 67 0.9× 28 491
Jani Liimatta Finland 8 199 0.9× 57 0.5× 237 2.3× 130 1.4× 18 0.2× 19 472

Countries citing papers authored by Burkhard L. Herrmann

Since Specialization
Citations

This map shows the geographic impact of Burkhard L. Herrmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Burkhard L. Herrmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Burkhard L. Herrmann more than expected).

Fields of papers citing papers by Burkhard L. Herrmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Burkhard L. Herrmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Burkhard L. Herrmann. The network helps show where Burkhard L. Herrmann may publish in the future.

Co-authorship network of co-authors of Burkhard L. Herrmann

This figure shows the co-authorship network connecting the top 25 collaborators of Burkhard L. Herrmann. A scholar is included among the top collaborators of Burkhard L. Herrmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Burkhard L. Herrmann. Burkhard L. Herrmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Sander, Ingrid, Sabine Kespohl, Eva Zahradnik, et al.. (2022). Quantitative measurement of IgG to SARS‐CoV‐2 antigens using monoclonal antibody‐based enzyme‐linked immunosorbent assays. Clinical & Translational Immunology. 11(2). e1369–e1369. 7 indexed citations
2.
Herrmann, Burkhard L.. (2020). Die Prävalenz von SARS-CoV-2-IgG-AK liegt bei 1,2%. MMW - Fortschritte der Medizin. 162(14). 44–46. 5 indexed citations
3.
Herrmann, Burkhard L.. (2020). [The prevalence rate of anti-SARS-CoV-2-IgG is 1.2% - Screening in asymptomatic outpatients in Germany (Northrhine-Westfalia)].. PubMed Central. 162(14). 44–46. 5 indexed citations
4.
Herrmann, Burkhard L., et al.. (2017). Obstructive Sleep Apnea Syndrome Is Less Frequent in Patients With Well-Controlled Acromegaly Treated With Somatostatin Analogues, Pegvisomant or in Combination. Journal of Endocrinology and Metabolism. 7(5). 141–145. 1 indexed citations
5.
Wolf, Claudia, Sebastian Ocklenburg, Burkhard L. Herrmann, et al.. (2013). Variability in ratings of trustworthiness across the menstrual cycle. Biological Psychology. 93(1). 52–57. 21 indexed citations
6.
Berg, Christian, Stephan Petersenn, Harald Lahner, et al.. (2010). Cardiovascular Risk Factors in Patients with Uncontrolled and Long-Term Acromegaly: Comparison with Matched Data from the General Population and the Effect of Disease Control. The Journal of Clinical Endocrinology & Metabolism. 95(8). 3648–3656. 100 indexed citations
7.
Galbán, Craig J., et al.. (2007). Changes in calf muscle elasticity in hypogonadal males before and after testosterone substitution as monitored by magnetic resonance elastography. European Journal of Endocrinology. 156(6). 673–678. 21 indexed citations
8.
9.
Bruch, Christian, Burkhard L. Herrmann, Axel Schmermund, et al.. (2002). Impact of disease activity on left ventricular performance in patients with acromegaly. American Heart Journal. 144(3). 538–543. 21 indexed citations
10.
Herrmann, Burkhard L., Bernhard Saller, Onno E. Janßen, et al.. (2002). Impact of Estrogen Replacement Therapy in a Male with Congenital Aromatase Deficiency Caused by a Novel Mutation in the CYP19 Gene. The Journal of Clinical Endocrinology & Metabolism. 87(12). 5476–5484. 167 indexed citations
11.
Herrmann, Burkhard L., Helmut Schatz, & Andreas Pfeiffer. (1998). Kontinuierliche Blutglucosemessungen: Der Akuteffekt von Acarbose auf die Blutglucoseschwankungen. Medizinische Klinik. 93(11). 651–655. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elisabete Rodrigues Breakdown of academic impact, for papers by M.T. Muñoz-Calvo Breakdown of academic impact, for papers by Veerle Bogaert Breakdown of academic impact, for papers by François Rey Breakdown of academic impact, for papers by Sumika Matsui Breakdown of academic impact, for papers by Anastasia Armeni Breakdown of academic impact, for papers by P H Rayner Breakdown of academic impact, for papers by Ruiyi Tang Breakdown of academic impact, for papers by C Preeyasombat Breakdown of academic impact, for papers by Jani Liimatta
Rankless by CCL
2026